Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Authors
In Silico Pharmacology provides a forum for research articles conceiving the interface between computational and experimental work in pharmacology and toxicology. The journal addresses computational approaches in drug design and multi-scale analysis of bioactive substances from the cellular up to the behavioural level.
Journal information
- Editor-in-Chief
-
- Boris Gutkin,
- Pramod Nair,
- Defang Ouyang,
- Chang-Guo Zhan
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 34 days
- Submission to first decision
- 164 days
- Submission to acceptance
- 12,761 (2019)
- Downloads
Latest issue
Latest articles
-
-
-
Synthesis and biological activity of 4-amino-3-chloro-1H-pyrrole-2,5-diones
Authors (first, second and last of 8)
-
Quantum chemical calculation and binding modes of H1R; a combined study of molecular docking and DFT for suggesting therapeutically potent H1R antagonist
Authors (first, second and last of 4)
-
Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction
Authors (first, second and last of 5)
About this journal
- Electronic ISSN
- 2193-9616
- Abstracted and indexed in
-
- BIOSIS
- CNKI
- Dimensions
- EBSCO Academic Search
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest Central
- ProQuest Computer Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- Copyright information
